Biohaven

Biohaven Profit per Employee

The Profit per Employee of Biohaven (BHVN) as of Oct 31, 2026 is -2.70 M USD. In the previous year, Profit per Employee was -3.09 M USD — a change of -12.71% (higher).

Profit per Employee

-2.70 MUSD

YoY

-12.71%

Last updated:

Profit per Employee of Biohaven is 2025 -2.70 M USD. Profit per Employee of Biohaven was 2024 -3.09 M USD. It decreases by -12.71% higher compared to the previous year.

The Biohaven Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
-879,270.07 USD
Jan 1, 2019
-1.93 M USD
Jan 1, 2020
-433,094.89 USD
Jan 1, 2021
-780,277.37 USD
Jan 1, 2022
-2.08 M USD
Jan 1, 2023
-1.49 M USD
Jan 1, 2024
-3.09 M USD
Jan 1, 2025
-2.70 M USD
The Biohaven Profit per Employee history
YEARProfit per EmployeeYoY
-2.70 MUSD-12.71%
-3.09 MUSD+107.37%
-1.49 MUSD-28.43%
-2.08 MUSD+166.74%
-780,277.37USD+80.16%
-433,094.89USD-77.56%
-1.93 MUSD+119.49%
-879,270.07USD+278.33%
-232,408.76USD+533.00%
-36,715.33USD+589.04%
-5,328.47USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohaven Stock analysis

What does Biohaven do? Biohaven Pharmaceutical Holding Co. Ltd. generates revenue through the research and development of late-stage product candidates targeting neurological diseases and rare disorders. The company utilizes its glutamate platform to advance clinical-stage compounds for various indications, including trigriluzole for obsessive-compulsive disorder, spinocerebellar ataxia, and Alzheimer's disease. Additionally, the firm develops BHV-0223 for amyotrophic lateral sclerosis and BHV-5000 for conditions such as Rett syndrome, neuropathic pain, and treatment-resistant depression. The business model focuses on identifying and developing clinical-stage compounds that target orphan neurologic indications and other neurological pathways, with the company currently employing 825 full-time employees in New Haven, Connecticut. Biohaven is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biohaven stock

Profit per Employee of Biohaven is -2.70 M USD in 2025.

Profit per Employee of Biohaven changed from -3.09 M USD to -2.70 M USD, representing a -12.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Biohaven since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Biohaven historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Biohaven

All Key Metrics — Biohaven